Related Experiment Video
Updated: May 29, 2026

Single Cell Measurement of Dopamine Release with Simultaneous Voltage-clamp and Amperometry
Published on: November 21, 2012
Acetylcholine from the mesopontine tegmental nuclei differentially affects methamphetamine induced locomotor activity
Lauren K Dobbs1, Gregory P Mark
1Department of Behavioral Neuroscience, Oregon Health & Sciences University, School of Medicine, 3181 Sam Jackson Park Rd., Portland, OR 97239, United States. dobbsl@ohsu.edu
Abstract:
Methamphetamine (MA) increases dopamine (DA) levels within the mesolimbic pathway and acetylcholine (ACh), a neurotransmitter known to increase DA cell firing and release and mediate reinforcement, within the ventral tegmental area (VTA). The laterodorsal tegmental (LDT) and pedunculopontine tegmental (PPT) nuclei provide cholinergic input to the VTA; however, the contribution of LDT- and PPT-derived ACh to MA-induced DA and ACh levels and locomotor activation remains unknown. The first experiment examined the role of LDT-derived ACh in MA locomotor activation by reversibly inhibiting these neurons with bilateral intra-LDT microinjections of the M2 receptor agonist oxotremorine (OXO). Male C57BL/6J mice were given a bilateral 0.1microl OXO (0, 1, or 10nM/side) microinjection immediately prior to IP saline or MA (2mg/kg). The highest OXO concentration significantly inhibited both saline- and MA-primed locomotor activity. In a second set of experiments we characterized the individual contributions of ACh originating in the LDT or pedunculopontine tegmental nucleus (PPT) to MA-induced levels of ACh and DA by administering intra-LDT or PPT OXO and performing in vivo microdialysis in the VTA and NAc. Intra-LDT OXO dose-dependently attenuated the MA-induced increase in ACh within the VTA but had no effect on DA in NAc. Intra-PPT OXO had no effect on ACh or DA levels within the VTA or NAc, respectively. We conclude that LDT, but not PPT, ACh is important in locomotor behavior and the cholinergic, but not dopaminergic, response to systemic MA.
Insights
Laterodorsal tegmental (LDT) acetylcholine (ACh) influences methamphetamine (MA) effects on locomotion and brain chemistry. LDT-derived ACh is crucial for MA-induced locomotor activity and the cholinergic, but not dopaminergic, response to MA.
Area of Science:
- Neuroscience
- Pharmacology
- Behavioral Science
Background:
- Methamphetamine (MA) elevates dopamine (DA) in the mesolimbic pathway and acetylcholine (ACh) in the ventral tegmental area (VTA).
- The laterodorsal tegmental (LDT) and pedunculopontine tegmental (PPT) nuclei are primary sources of VTA cholinergic input.
- The specific roles of LDT- and PPT-derived ACh in MA's effects on DA, ACh, and locomotion are not fully understood.
Purpose of the Study:
- To investigate the contribution of LDT-derived ACh to MA-induced locomotor activation.
- To determine the individual roles of LDT and PPT ACh in modulating MA-induced ACh and DA levels in the VTA and nucleus accumbens (NAc).
Main Methods:
- Reversible inhibition of LDT neurons using intra-LDT microinjections of the M2 receptor agonist oxotremorine (OXO) in mice.
- Assessment of locomotor activity following OXO administration before saline or MA injection.
- In vivo microdialysis in the VTA and NAc to measure ACh and DA levels after intra-LDT or intra-PPT OXO administration.
Main Results:
- High-dose OXO in the LDT significantly reduced both saline- and MA-induced locomotor activity.
- Intra-LDT OXO dose-dependently attenuated the MA-induced increase in VTA ACh levels.
- Neither intra-LDT nor intra-PPT OXO affected MA-induced DA levels in the NAc, and intra-PPT OXO did not alter ACh levels in the VTA.
Conclusions:
- ACh originating from the LDT, but not the PPT, plays a significant role in locomotor behavior.
- LDT-derived ACh is critical for the cholinergic, but not the dopaminergic, neurochemical response to systemic MA.
- These findings highlight the specific involvement of LDT cholinergic pathways in mediating behavioral and neurochemical effects of MA.
Related Concept Videos
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
Cholinergic Neurons: Neurotransmission
Neurochemical Transmission: Sites of Drug Action
Drugs Affecting Neurotransmitter Synthesis
Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
The direct-acting...

